SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRentokil Initial Regulatory News (RTO)

Share Price Information for Rentokil Initial (RTO)

Share Price is delayed by 15 minutes
Get Live Data
453.60    3.80 (0.84%)
Bid:
452.90
Ask:
453.20
Spread: 0.30 (0.066%)
Market Cap: £11.41b
RTO Live PriceLast checked at - London Stock Exchange

Intraday Rentokil Initial Share Chart

Pension Scheme Deficit

19 Dec 2005 10:25

Rentokil Initial PLC19 December 2005 19 December 2005 RENTOKIL INITIAL plc ADDRESSES PENSION SCHEME DEFICIT In its third quarter update on 3 November 2005, Rentokil Initial plc ("theCompany") announced that it was in discussions with the Trustees of the DefinedBenefit (DB) Sections of the Rentokil Initial Pension Scheme ("the Scheme")regarding measures to address the Scheme's funding deficit and to ensureappropriate future funding levels. These discussions have resulted in thecompany proposing a series of positive steps which will deal with these issuesand protect the security of the Scheme's benefits for its members. The deficit of the UK Scheme under IAS 19 as at 30 November 2005 was estimatedto be Β£325 million. In response to a general trend of increasing longevity,which has adversely impacted the Scheme, the Company and Trustees have agreed toa more prudent basis for estimating longevity that will increase this deficit byan additional Β£24 million. An agreement has been reached between the Companyand the Trustees to make an immediate payment of Β£200 million, with theremaining deficit being met by a series of payments ending no later than January2012. The changed regulatory environment for pensions requires the Company todeal with these issues in a shorter timescale than it might otherwise have done.The total funding required to address the deficit will be in the range of Β£370million to Β£380 million depending on the final timing of the payments. In order to reduce the likelihood that the scheme deficit will increasematerially in the future, following discussions with the Company, the Trusteeswill be reviewing the Scheme's investment strategy, with the aim of reducingpotential volatility that might be caused by market movements. This will resultin a lower exposure to equities over time and improve the security of Schemebenefits. With immediate effect, the Company will be entering into a period ofcomprehensive consultation with active members of the DB Sections of the Scheme.The Company is proposing to close the DB Sections for the future accrual ofbenefits for active members. The aim of this is to reduce exposure to futureshortfalls and to ensure that the Scheme will be in a position to continue topay all benefits that have been earned to date by its members. It will alsoprovide the Company with more predictable costs of future pension provision.The proposed closure will have no impact on the scheme's deferred pensioners andpensions in payment. If the Company's proposals are implemented, existing active members of theScheme's DB Sections will be offered membership in a defined contributionarrangement so that they can continue to make provision for retirement. Final decisions regarding the review will be taken once the consultation periodwith active members has been completed later in 2006. Shareholder/analyst enquiriesAndrew Macfarlane, CFO Tel: 01342 833022Lisa Williams, Investor Relations Tel: 01342 833022 Media enquiriesCharles Grimaldi, Corporate Affairs Director Tel: 01342 833022Gill Ackers/Kate Miller, Brunswick Group LLP Tel: 020 7404 5959 Notes to editors: The Defined Benefit Sections of the Rentokil Initial Pension Scheme currentlyhas 3,000 active members, 15,000 deferred pensioners and 8,000 pensions inpayment. At 30 November 2005, the scheme had assets of Β£640 million and liabilities ofΒ£965 million. In the Lane Clark Peacock Accounting for Pensions Annual Survey 2005, RentokilInitial had the 96th lowest level of pension scheme funding out of the FTSE-100. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
28th Jul 20253:00 pmRNSHolding(s) in Company
10th Jul 202511:00 amRNSHolding(s) in Company
1st Jul 202510:25 amRNSTotal Voting Rights
10th Jun 202510:05 amRNSAdditional Listing
3rd Jun 20254:00 pmRNSDirector/PDMR Shareholding
28th May 20257:00 amRNSSale of France Workwear
19th May 20252:30 pmRNSDirector/PDMR Shareholding
7th May 20254:15 pmRNSResult of AGM
7th May 20257:01 amRNSDirectorate Change: Appointment of NEDs
7th May 20257:00 amRNSDirectorate Change: Chief Executive to retire
28th Apr 20252:30 pmRNSIssue of Debt
17th Apr 20252:20 pmRNSHolding(s) in Company
17th Apr 20257:00 amRNSQ1 Trading Update
9th Apr 202510:25 amRNSHolding(s) in Company
1st Apr 20252:15 pmRNSNotice of Q1 Trading Update and Management Call
1st Apr 202510:25 amRNSBlock listing Interim Review
27th Mar 202510:25 amRNSDirector/PDMR Shareholding
26th Mar 202510:30 amRNSAnnual Financial Report
14th Mar 202510:00 amRNSDirector/PDMR Shareholding
6th Mar 20257:00 amRNSFinal Results
28th Jan 20257:00 amRNSTrading Update (unaudited)
14th Jan 202511:15 amRNSHolding(s) in Company
13th Jan 202511:15 amRNSHolding(s) in Company
13th Dec 20249:30 amRNSDirector/PDMR Shareholding
25th Nov 20247:00 amRNSDirectorate Change
12th Nov 202410:30 amRNSHolding(s) in Company
8th Nov 202410:30 amRNSHolding(s) in Company
17th Oct 20247:00 amRNSQ3 Trading Update
1st Oct 20242:00 pmRNSBlock listing Interim Review
25th Sep 20247:00 amRNSAppointment of Non-Executive Director
19th Sep 202410:30 amRNSDirector/PDMR Shareholding
11th Sep 20247:00 amRNSTrading Update
10th Sep 202410:30 amRNSHolding(s) in Company
5th Sep 202411:08 amRNSHolding(s) in Company
25th Jul 20247:00 amRNS2024 Interim Results
10th Jul 20244:35 pmRNSHolding(s) in Company
26th Jun 20245:12 pmRNSDirector/PDMR Shareholding
26th Jun 202411:08 amRNSHolding(s) in Company
17th May 20243:30 pmRNSDirector/PDMR Shareholding
8th May 20242:00 pmRNSResult of AGM
29th Apr 20243:00 pmRNSHolding(s) in Company
23rd Apr 20249:30 amRNSHolding(s) in Company
18th Apr 20247:00 amRNSQ1 Trading Update
2nd Apr 20241:28 pmRNSBlock listing Interim Review
2nd Apr 202412:17 pmRNSTotal Voting Rights
27th Mar 202410:23 amRNSAnnual Financial Report
19th Mar 20242:05 pmRNSAdditional Listing
14th Mar 202410:19 amRNSDirector/PDMR Shareholding
7th Mar 20247:00 amRNSFinal Results
1st Dec 20237:00 amRNSNorth American Management Changes

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.